These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1372400)

  • 1. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
    Espino PC; Chou WY; Smith AE; Cheng SH
    Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.
    Cheng SH; Espino PC; Marshall J; Harvey R; Merrill J; Smith AE
    J Virol; 1991 Jan; 65(1):170-9. PubMed ID: 1985196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
    Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
    Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Harvey R; Espino PC; Semba K; Yamamoto T; Toyoshima K; Smith AE
    EMBO J; 1988 Dec; 7(12):3845-55. PubMed ID: 2463167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the non-catalytic domains of Fyn and Fgr tyrosine kinases reveal differences in mechanisms of their regulation.
    Rivero-Lezcano OM; Marcilla A; Robbins KC
    Oncogene; 1995 Dec; 11(12):2675-9. PubMed ID: 8545125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo phosphorylation and membrane association of the fyn proto-oncogene product in IM-9 human lymphoblasts.
    Peters DJ; McGrew BR; Perron DC; Liptak LM; Laudano AP
    Oncogene; 1990 Sep; 5(9):1313-9. PubMed ID: 1699196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine phosphorylation of a 120,000 dalton membrane-associated protein by the neural form of pp60c-src, pp60c-src+.
    Flynn DC; Schaller MD; Parsons JT
    Oncogene; 1992 Mar; 7(3):579-83. PubMed ID: 1372401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pp60c-src expression is induced by activation of normal human T lymphocytes.
    Branch DR; Mills GB
    J Immunol; 1995 Apr; 154(8):3678-85. PubMed ID: 7535811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation.
    Twamley GM; Kypta RM; Hall B; Courtneidge SA
    Oncogene; 1992 Oct; 7(10):1893-901. PubMed ID: 1408131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
    Brickell PM
    Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation and regulatory effects of the carboxy terminus of a Drosophila src homolog.
    Kussick SJ; Cooper JA
    Oncogene; 1992 Aug; 7(8):1577-86. PubMed ID: 1630818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.